Digestive Health

News Watch

Research & Practice

Discover the first video interview from our Gut Microbiota for Health World Summit 2014 serie. The event took place in Miami, Florida, USA on March 8-9, 2014. Prof. Balfour Sartor hosted a workshop on the role of intestinal microbiota in IBD and shared his conclusions with us. http://video.gutmicrobiotaforhealth.com/gmfh2014-interviews/Balfour-Sartor.mp4

Discover the first video interview from our Gut Microbiota for Health World Summit 2014 serie. The event took place in Miami, Florida, USA on March 8-9, 2014. Prof. Balfour Sartor hosted a workshop on the role of intestinal microbiota in IBD and shared his conclusions with us. http://video.gutmicrobiotaforhealth.com/gmfh2014-interviews/Balfour-Sartor.mp4

At the occasion of the "New therapies in coeliac disease" conference hosted by Columbia University in New-York on March 20, 2014, Dr. Elena Verdú, our expert in Nutrition, is sharing with us the last trends in research in the field of Coeliac Disease (CeD), introducing the idea of a role of probiotics in the treatment of CeD. Presence of intestinal dysbiosis…

Elena VerdúDr. Verdu’s research has focused on the pathophysiology of inflammatory and functional gastrointestinal disorders. She undertook clinical research training at the University of Lausanne, Switzerland, where she studied the interaction between chronic infection with Helicobacter pylori and gastritis in humans and the possible therapeutic role of probiotic bacteria.
Her PhD studies in the Institute of Microbiology and Gnotobiology at the Czech Academy of Science and University of Lausanne focused on the effect of bacterial antigens in animal models of inflammatory bowel disease. As a post-doctoral fellow at McMaster University she gained experience with animal models of gut functional diseases and investigated the mechanisms of action of probiotic bacteria.
As a member of the Farncombe Family Digestive Health Research Institute at McMaster University, Dr. Verdu investigates host-microbial and dietary interactions in the context of celiac disease, irritable bowel syndrome and inflammatory bowel disease. She has been honored with the New Investigator Award (Canadian Celiac Association), the New Investigator Award (Functional Gut-Brain Research Group, USA) and the Campbell Research Award in celiac disease (Canadian Celiac Association). The American Gastroenterology Association and the Canadian Association of Gastroenterology have awarded her the “Master’s in Gastroenterology Award” for basic science and “Young Investigator’s Award”, respectively.
She is Associate Professor at the Division of Gastroenterology, Dep. of Medicine at McMaster University and currently directs the Axenic Gnotobiotic Unit at McMaster.

At the occasion of the "New therapies in coeliac disease" conference hosted by Columbia University in New-York on March 20, 2014, Dr. Elena Verdú, our expert in Nutrition, is sharing with us the last trends in research in the field of Coeliac Disease (CeD), introducing the idea of a role of probiotics in the treatment of CeD. Presence of intestinal dysbiosis…

Elena VerdúDr. Verdu’s research has focused on the pathophysiology of inflammatory and functional gastrointestinal disorders. She undertook clinical research training at the University of Lausanne, Switzerland, where she studied the interaction between chronic infection with Helicobacter pylori and gastritis in humans and the possible therapeutic role of probiotic bacteria.
Her PhD studies in the Institute of Microbiology and Gnotobiology at the Czech Academy of Science and University of Lausanne focused on the effect of bacterial antigens in animal models of inflammatory bowel disease. As a post-doctoral fellow at McMaster University she gained experience with animal models of gut functional diseases and investigated the mechanisms of action of probiotic bacteria.
As a member of the Farncombe Family Digestive Health Research Institute at McMaster University, Dr. Verdu investigates host-microbial and dietary interactions in the context of celiac disease, irritable bowel syndrome and inflammatory bowel disease. She has been honored with the New Investigator Award (Canadian Celiac Association), the New Investigator Award (Functional Gut-Brain Research Group, USA) and the Campbell Research Award in celiac disease (Canadian Celiac Association). The American Gastroenterology Association and the Canadian Association of Gastroenterology have awarded her the “Master’s in Gastroenterology Award” for basic science and “Young Investigator’s Award”, respectively.
She is Associate Professor at the Division of Gastroenterology, Dep. of Medicine at McMaster University and currently directs the Axenic Gnotobiotic Unit at McMaster.

Elena Buelow published under Willem van Schaik's supervision her work about the monitoring of patients in intensive care units to assess the selective digestive decontamination using a metagenomics approach. She accepted to give us highlights of her study which give new insight about the gut resistome. 1) What is your background? I have obtained my Master’s degree in Medical Biology…

Elena Buelow published under Willem van Schaik's supervision her work about the monitoring of patients in intensive care units to assess the selective digestive decontamination using a metagenomics approach. She accepted to give us highlights of her study which give new insight about the gut resistome. 1) What is your background? I have obtained my Master’s degree in Medical Biology…

In this study, Aviles-Jimenez and co-workers aimed to characterize microbiota of the gastric mucosa as its progress to intestinal type of cancer. To do that, they analysed gastric tissue in patients with non-atrophic gastritis (NAG), intestinal metaplasia (IM) and intestinal-type gastric cancer (GC). After performing genetic analyses on the samples, the researchers quantified a low bacterial diversity in all samples,…

In this study, Aviles-Jimenez and co-workers aimed to characterize microbiota of the gastric mucosa as its progress to intestinal type of cancer. To do that, they analysed gastric tissue in patients with non-atrophic gastritis (NAG), intestinal metaplasia (IM) and intestinal-type gastric cancer (GC). After performing genetic analyses on the samples, the researchers quantified a low bacterial diversity in all samples,…

Dr Elena Verdú's lab seeks to understand the complex pathophysiology of gastrointestinal disease, with a focus on microbiota-diet interactions, to identify novel therapeutic targets for these disorders. 1/ What strikes you most in the evolution of research on gut microbiota and why? One interesting aspect relates to the way we have approached the study of the microbiota. We…

Dr Elena Verdú's lab seeks to understand the complex pathophysiology of gastrointestinal disease, with a focus on microbiota-diet interactions, to identify novel therapeutic targets for these disorders. 1/ What strikes you most in the evolution of research on gut microbiota and why? One interesting aspect relates to the way we have approached the study of the microbiota. We…

SITEMAP

CONTACT US

ABOUT US

Gut Microbiota for Health has been created by the Gut Microbiota and Health Section of the European Society for Neurogastroenterology & Motility (ESNM), member of United European Gastroenterology (UEG)